Wang XJ - Search Results

1

KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.

He W, Zhang MG, Wang XJ, Zhong S, Shao Y, Zhu Y, Shen ZJ. He W, et al. Among authors: wang xj. Int J Clin Exp Pathol. 2013 Nov 15;6(12):2864-71. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24294372 Free PMC article.

2

CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin.

Gao F, Xu T, Wang X, Zhong S, Chen S, Zhang M, Zhang X, Shen Y, Wang X, Xu C, Shen Z. Gao F, et al. J Exp Clin Cancer Res. 2017 May 18;36(1):70. doi: 10.1186/s13046-017-0539-8. J Exp Clin Cancer Res. 2017. PMID: 28521777 Free PMC article.

3

Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (< or =1 cm): the Ruijin clinical experience in 88 patients.

Wang XJ, Shen ZJ, Zhu Y, Zhang RM, Shun FK, Shao Y, Rui WB, He W. Wang XJ, et al. BJU Int. 2010 Mar;105(6):849-53. doi: 10.1111/j.1464-410X.2009.08878.x. Epub 2009 Sep 14. BJU Int. 2010. PMID: 19751254

4

AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment.

He W, Zhang MG, Wang XJ, Zhong S, Shao Y, Zhu Y, Shen ZJ. He W, et al. Among authors: wang xj. Am J Transl Res. 2013 Apr 19;5(3):359-67. Print 2013. Am J Transl Res. 2013. PMID: 23634246 Free PMC article.

5

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.

Gao F, Wang X, Chen S, Xu T, Wang X, Shen Y, Dong F, Zhong S, Shen Z. Gao F, et al. Oncol Rep. 2018 Nov;40(5):2445-2454. doi: 10.3892/or.2018.6641. Epub 2018 Aug 10. Oncol Rep. 2018. PMID: 30106121 Free PMC article.

6

HSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways.

Xu F, Lin D, Jiang W, Meng L, Xu Y, Wang C, Wang X, He H, Xu D, Zhu Y. Xu F, et al. Int J Clin Exp Pathol. 2019 Jul 1;12(7):2585-2594. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934086 Free PMC article.

7

Associations between the expressions of MiR-135 and MiR-92a and pathogenesis of prostate cancer and analysis of their clinical significance.

He W, He H, Zhang N, Rui W, Wang X, Zhu Y, Xie X. He W, et al. J BUON. 2020 May-Jun;25(3):1619-1624. J BUON. 2020. PMID: 32862613 Free article.

8

METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.

Wang D, Wang X, Huang B, Zhao Y, Tu W, Jin X, Shao Y, Zhu Y, Lu G. Wang D, et al. Andrologia. 2022 Aug;54(7):1581-1591. doi: 10.1111/and.14422. Epub 2022 Apr 12. Andrologia. 2022. PMID: 35413135

9

Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cm.

Fang C, Xie X, Xu T, He W, He H, Wang X, Zhu Y, Shen Z, Shao Y. Fang C, et al. Int Urol Nephrol. 2017 Jul;49(7):1177-1182. doi: 10.1007/s11255-017-1576-0. Epub 2017 Mar 25. Int Urol Nephrol. 2017. PMID: 28343326

10

TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer.

Wang X, He H, Rui W, Zhang N, Zhu Y, Xie X. Wang X, et al. J Transl Med. 2021 Dec 14;19(1):508. doi: 10.1186/s12967-021-03173-x. J Transl Med. 2021. PMID: 34906161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,448 results

Search Page

Filters